Pharmacological and interventional treatment of phantom pain
DOI:
https://doi.org/10.25305/unj.318305Keywords:
phantom limb pain, personalized approach, treatment methods, pharmacotherapy, interventional treatmentAbstract
Phantom limb pain (PLP) is a common and debilitating form of neuropathic pain that occurs after limb amputation significantly impairing patients' quality of life.
The aim of this review is to summarize and analyze current data on pharmacological and interventional treatments for PLP, focusing on practical aspects of therapy to improve patients' quality of life and optimize treatment strategies for this complex condition.
A review of recent studies and clinical guidelines on PLP management was conducted, including pharmacological approaches (antidepressants, anticonvulsants, gabapentinoids, opioids, and NMDA receptor antagonists) and interventional methods (nerve blocks, radiofrequency procedures, neuromodulation).
Pharmacological treatment of PLP has shown variable outcomes. Gabapentinoids, anticonvulsants, and serotonin-norepinephrine reuptake inhibitors have demonstrated moderate efficacy in reducing pain intensity. Opioids may be used only in severe cases due to the risk of dependency and side effects. Interventional methods such as peripheral nerve blocks, radiofrequency ablation, and neuromodulation techniques (spinal cord stimulation, transcranial magnetic stimulation) provide long-term pain relief in refractory PLP cases with minimal side effects.
A personalized approach combining pharmacological and interventional methods appears to be the most effective in managing PLP. Further randomized controlled trials are needed to optimize therapeutic strategies. Given the increasing number of amputees due to military actions in Ukraine, the standardization of PLP treatment has become a priority for the medical community.
References
1. Limakatso K, Bedwell GJ, Madden VJ, Parker R. The prevalence and risk factors for phantom limb pain in people with amputations: A systematic review and meta-analysis. PLoS One. 2020 Oct 14;15(10):e0240431. [CrossRef] [PubMed] [PubMed Central]
2. Stankevicius A, Wallwork SB, Summers SJ, Hordacre B, Stanton TR. Prevalence and incidence of phantom limb pain, phantom limb sensations and telescoping in amputees: A systematic rapid review. Eur J Pain. 2021 Jan;25(1):23-38. [CrossRef] [PubMed]
3. Ishigami S, Boctor C. Epidemiology and risk factors for phantom limb pain. Front Pain Res (Lausanne). 2024 Aug 21;5:1425544. [CrossRef] [PubMed] [PubMed Central]
4. Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008 Mar;89(3):422-9. [CrossRef] [PubMed]
5. Yin Y, Zhang L, Xiao H, Wen CB, Dai YE, Yang G, Zuo YX, Liu J. The pre-amputation pain and the postoperative deafferentation are the risk factors of phantom limb pain: a clinical survey in a sample of Chinese population. BMC Anesthesiol. 2017 May 26;17(1):69. [CrossRef] [PubMed] [PubMed Central]
6. Münger M, Pinto CB, Pacheco-Barrios K, Duarte D, Enes Gunduz M, Simis M, Battistella LR, Fregni F. Protective and Risk Factors for Phantom Limb Pain and Residual Limb Pain Severity. Pain Pract. 2020 Jul;20(6):578-587. [CrossRef] [PubMed] [PubMed Central]
7. Penna A, Konstantatos AH, Cranwell W, Paul E, Bruscino-Raiola FR. Incidence and associations of painful neuroma in a contemporary cohort of lower-limb amputees. ANZ J Surg. 2018 May;88(5):491-496. [CrossRef] [PubMed]
8. de Lange JWD, Hundepool CA, Power DM, Rajaratnam V, Duraku LS, Zuidam JM. Prevention is better than cure: Surgical methods for neuropathic pain prevention following amputation - A systematic review. J Plast Reconstr Aesthet Surg. 2022 Mar;75(3):948-959. [CrossRef] [PubMed]
9. Gallagher P, Allen D, Maclachlan M. Phantom limb pain and residual limb pain following lower limb amputation: a descriptive analysis. Disabil Rehabil. 2001 Aug 15;23(12):522-30. [CrossRef] [PubMed]
10. Dietrich C, Nehrdich S, Seifert S, Blume KR, Miltner WHR, Hofmann GO, Weiss T. Leg Prosthesis With Somatosensory Feedback Reduces Phantom Limb Pain and Increases Functionality. Front Neurol. 2018 Apr 26;9:270. [CrossRef] [PubMed] [PubMed Central]
11. Griffin SC, Alphonso AL, Tung M, Finn S, Perry BN, Hill W, O'Connell C, Hanling SR, Goff BJ, Pasquina PF, Tsao J. Characteristics of phantom limb pain in U.S. civilians and service members. Scand J Pain. 2021 Sep 16;22(1):125-132. [CrossRef] [PubMed] [PubMed Central]
12. Ephraim PL, Wegener ST, MacKenzie EJ, Dillingham TR, Pezzin LE. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil. 2005 Oct;86(10):1910-9. [CrossRef] [PubMed]
13. Jensen MP, Ehde DM, Hoffman AJ, Patterson DR, Czerniecki JM, Robinson LR. Cognitions, coping and social environment predict adjustment to phantom limb pain. Pain. 2002 Jan;95(1-2):133-42. [CrossRef] [PubMed]
14. Morgan SJ, Friedly JL, Amtmann D, Salem R, Hafner BJ. Cross-Sectional Assessment of Factors Related to Pain Intensity and Pain Interference in Lower Limb Prosthesis Users. Arch Phys Med Rehabil. 2017 Jan;98(1):105-113. [CrossRef] [PubMed] [PubMed Central]
15. Stone AB, Hollmann MW, Terwindt LE, Lirk P. Chronic post amputation pain: pathophysiology and prevention options for a heterogenous phenomenon. Curr Opin Anaesthesiol. 2023 Oct 1;36(5):572-579. [CrossRef] [PubMed]
16. Culp CJ, Abdi S. Current Understanding of Phantom Pain and its Treatment. Pain Physician. 2022 Oct;25(7):E941-E957. [PubMed]
17. Robinson LR, Czerniecki JM, Ehde DM, Edwards WT, Judish DA, Goldberg ML, Campbell KM, Smith DG, Jensen MP. Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Arch Phys Med Rehabil. 2004 Jan;85(1):1-6. [CrossRef] [PubMed]
18. Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012 Jan;52(1):6-17. [CrossRef] [PubMed]
19. Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006380. [CrossRef] Update in: Cochrane Database Syst Rev. 2016 Oct 14;10:CD006380. [CrossRef] [PubMed]
20. Qi HX, Stepniewska I, Kaas JH. Reorganization of primary motor cortex in adult macaque monkeys with long-standing amputations. J Neurophysiol. 2000 Oct;84(4):2133-47. [CrossRef] [PubMed]
21. Malik Tariq, ed. Practical Chronic Pain Management. A Case-Based Approach. Springer, Switzerland, 2020.
22. Smith DG, Ehde DM, Hanley MA, Campbell KM, Jensen MP, Hoffman AJ, Awan AB, Czerniecki JM, Robinson LR. Efficacy of gabapentin in treating chronic phantom limb and residual limb pain. J Rehabil Res Dev. 2005 Sep-Oct;42(5):645-54. [CrossRef] [PubMed]
23. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med. 2002 Sep-Oct;27(5):481-6. [CrossRef] [PubMed]
24. Urits I, Seifert D, Seats A, Giacomazzi S, Kipp M, Orhurhu V, Kaye AD, Viswanath O. Treatment Strategies and Effective Management of Phantom Limb-Associated Pain. Curr Pain Headache Rep. 2019 Jul 29;23(9):64. [CrossRef] [PubMed]
25. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007076. [CrossRef] Update in: Cochrane Database Syst Rev. 2019 Jan 23;1:CD007076. [CrossRef] [PubMed] [PubMed Central]
26. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain. 2008 Nov;9(11):1006-17. [CrossRef] [PubMed]
27. Bornemann-Cimenti H, Dorn C, Rumpold-Seitlinger G. Early Onset and Treatment of Phantom Limb Pain Following Surgical Amputation. Pain Med. 2017 Dec 1;18(12):2510-2512. [CrossRef] [PubMed]
28. Marcial KMG, Arcilla MVRV. A Novel Approach in Treating Phantom Limb Pain Using Erector Spinae Plane Block. Acta Med Philipp. 2024 May 23;58(9):44-47. [CrossRef] [PubMed] [PubMed Central]
29. Wössner S, Weber K, Steinbeck AC, Oberhauser M, Feuerecker M. Pregabalin as adjunct in a multimodal pain therapy after traumatic foot amputation - A case report of a 4-year-old girl. Scand J Pain. 2017 Oct;17:146-149. [CrossRef] [PubMed]
30. Erlenwein J, Diers M, Ernst J, Schulz F, Petzke F. Clinical updates on phantom limb pain. Pain Rep. 2021 Jan 15;6(1):e888. [CrossRef] [PubMed] [PubMed Central]
31. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015 Feb;14(2):162-73. [CrossRef] [PubMed] [PubMed Central]
32. Arnold LM, McCarberg BH, Clair AG, Whalen E, Thomas N, Jorga A, Pauer L, Vissing R, Park PW. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia. Postgrad Med. 2017 Nov;129(8):921-933. [CrossRef] [PubMed]
33. Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgrad Med. 2021 Jan;133(1):1-9. [CrossRef] [PubMed]
34. Huffman CL, Goldenberg JN, Weintraub J, Sanin L, Driscoll J, Yang R, Chew ML, Scavone JM. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial. Clin J Pain. 2017 Jul;33(7):569-578. [CrossRef] [PubMed]
35. Spiegel DR, Lappinen E, Gottlieb M. A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin. Gen Hosp Psychiatry. 2010 Mar-Apr;32(2):228.e5-7. [CrossRef] [PubMed]
36. Tesfaye S, Wilhelm S, Lledo A, Schacht A, Tölle T, Bouhassira D, Cruccu G, Skljarevski V, Freynhagen R. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013 Dec;154(12):2616-2625. [CrossRef] [PubMed]
37. Zhou M, Chen N, He L, Yang M, Zhu C, Wu F. Oxcarbazepine for neuropathic pain. Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD007963. [CrossRef] [PubMed] [PubMed Central]
38. Wiffen PJ, Derry S, Lunn MP, Moore RA. Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2013 Aug 30;2013(8):CD008314. [CrossRef] [PubMed] [PubMed Central]
39. Hall N, Eldabe S. Phantom limb pain: a review of pharmacological management. Br J Pain. 2018 Nov;12(4):202-207. [CrossRef] [PubMed] [PubMed Central]
40. Israel JE, St Pierre S, Ellis E, Hanukaai JS, Noor N, Varrassi G, Wells M, Kaye AD. Ketamine for the Treatment of Chronic Pain: A Comprehensive Review. Health Psychol Res. 2021 Jul 10;9(1):25535. [CrossRef] [PubMed] [PubMed Central]
41. Jabbari B. Botulinum toxin treatment of pain disorders. Second Edition. New York, USA: Springer; 2022.
42. Reiestad F, Kulkarni J. Role of myofascial trigger points in post-amputation pain: causation and management. Prosthet Orthot Int. 2013 Apr;37(2):120-3. [CrossRef] [PubMed]
43. Ilfeld BM, Khatibi B, Maheshwari K, Madison SJ, Esa WAS, Mariano ER, Kent ML, Hanling S, Sessler DI, Eisenach JC, Cohen SP, Mascha EJ, Ma C, Padwal JA, Turan A; PAINfRE Investigators. Ambulatory continuous peripheral nerve blocks to treat postamputation phantom limb pain: a multicenter, randomized, quadruple-masked, placebo-controlled clinical trial. Pain. 2021 Mar 1;162(3):938-955. [CrossRef] [PubMed] [PubMed Central]
44. Zhang X, Xu Y, Zhou J, Pu S, Lv Y, Chen Y, Du D. Ultrasound-guided alcohol neurolysis and radiofrequency ablation of painful stump neuroma: effective treatments for post-amputation pain. J Pain Res. 2017 Feb 3;10:295-302. [CrossRef] [PubMed] [PubMed Central]
45. Gruber H, Glodny B, Kopf H, Bendix N, Galiano K, Strasak A, Peer S. Practical experience with sonographically guided phenol instillation of stump neuroma: predictors of effects, success, and outcome. AJR Am J Roentgenol. 2008 May;190(5):1263-9. [CrossRef] [PubMed]
46. Jorge DMF, Huber SC, Rodrigues BL, Da Fonseca LF, Azzini GOM, Parada CA, Paulus-Romero C, Lana JFSD. The Mechanism of Action between Pulsed Radiofrequency and Orthobiologics: Is There a Synergistic Effect? Int J Mol Sci. 2022 Oct 3;23(19):11726. [CrossRef] [PubMed] [PubMed Central]
47. Mercadal B, Vicente R, Ivorra A. Pulsed radiofrequency for chronic pain: In vitro evidence of an electroporation mediated calcium uptake. Bioelectrochemistry. 2020 Dec;136:107624. [CrossRef] [PubMed]
48. Vallejo R, Tilley DM, Williams J, Labak S, Aliaga L, Benyamin RM. Pulsed radiofrequency modulates pain regulatory gene expression along the nociceptive pathway. Pain Physician. 2013 Sep-Oct;16(5):E601-13. [PubMed]
49. Vanneste T, Van Lantschoot A, Van Boxem K, Van Zundert J. Pulsed radiofrequency in chronic pain. Curr Opin Anaesthesiol. 2017 Oct;30(5):577-582. [CrossRef] [PubMed]
50. Park D, Chang MC. The mechanism of action of pulsed radiofrequency in reducing pain: a narrative review. J Yeungnam Med Sci. 2022 Jul;39(3):200-205. [CrossRef] [PubMed] [PubMed Central]
51. Wilkes D, Ganceres N, Solanki D, Hayes M. Pulsed radiofrequency treatment of lower extremity phantom limb pain. Clin J Pain. 2008 Oct;24(8):736-9. [CrossRef] [PubMed]
52. West M, Wu H. Pulsed radiofrequency ablation for residual and phantom limb pain: a case series. Pain Pract. 2010 Sep-Oct;10(5):485-91. [CrossRef] [PubMed]
53. Kumar A, Kantha M, Goyal S, Atter P. Ultrasound-guided pulsed radiofrequency ablation of stellate ganglion in upper-extremity phantom limb pain: a case series. Anesth Pain Med (Seoul). 2024 Oct;19(4):349-352. [CrossRef] [PubMed] [PubMed Central]
54. Pu S, Wu J, Han Q, Zhang X, Lv Y, Xu Y, Li C, Du D. Ultrasonography-Guided Radiofrequency Ablation for Painful Stump Neuromas to Relieve Postamputation Pain: A Pilot Study. J Pain Res. 2020 Dec 18;13:3437-3445. [CrossRef] [PubMed] [PubMed Central]
55. Corbett M, South E, Harden M, Eldabe S, Pereira E, Sedki I, Hall N, Woolacott N. Brain and spinal stimulation therapies for phantom limb pain: a systematic review. Health Technol Assess. 2018 Nov;22(62):1-94. [CrossRef] [PubMed] [PubMed Central]
56. Pagan-Rosado R, Smith BJ, Smither FC, Pingree MJ, D'Souza RS. Peripheral Nerve Stimulation for the Treatment of Phantom Limb Pain: A Case Series. Case Rep Anesthesiol. 2023 Mar 6;2023:1558183. [CrossRef] [PubMed] [PubMed Central]
57. Pacheco-Barrios K, Meng X, Fregni F. Neuromodulation Techniques in Phantom Limb Pain: A Systematic Review and Meta-analysis. Pain Med. 2020 Oct 1;21(10):2310-2322. [CrossRef] [PubMed] [PubMed Central]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Vadym V. Biloshytsky, Maryna V. Biloshytska
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
